Could a Ketamine-Like drug ease OCD? new trial launches
NCT ID NCT06575075
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This study tests a new drug called RR-HNK to see if it can safely reduce OCD symptoms. About 45 adults with OCD who haven't been helped by standard treatments will receive either the drug or a placebo. The goal is to measure changes in obsessions and compulsions using a standard scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University School of Medicine
RECRUITINGPalo Alto, California, 94305, United States
Contact
Conditions
Explore the condition pages connected to this study.